• Investor Centre
    • Live Investor Briefing
    • Share Price and Announcements
    • Corporate Governance
  • About Us
  • News & media
    • Webcast Replays
      • Wellnex Life Q&A update with Zack Bozinovski
      • Unlocking the over-the-counter medicinal cannabis opportunity
  • Contact
  • Investor Centre
    • Live Investor Briefing
    • Share Price and Announcements
    • Corporate Governance
  • About Us
  • News & media
    • Webcast Replays
      • Wellnex Life Q&A update with Zack Bozinovski
      • Unlocking the over-the-counter medicinal cannabis opportunity
  • Contact
WNX - Small Caps

Wellnex Life reports record $3m in monthly sales as it pursues dual listing on LSE

Wellnex Life (ASX: WNX) has reported record sales of $3 million per month for November...

small caps

Wellnex Life on track to meet guidance as sales continue to grow

Consumer healthcare business Wellnex Life (ASX: WNX) has announced it is on track to meet its guidance...

wellnex_financials-768x432

Wellnex is a health and wellness darling as financials strengthen

Wellnex has demonstrated the strength of its health and wellness offerings with cash receipts for...

AdobeStock_286427705

Unlocking the over-the-counter medicinal cannabis opportunity

Company Explainer: Unlocking the over-the-counter medicinal cannabis opportunity CEO of Wellnex Life George Karafotias, Chief...

Covid-eBook-landing-page-768x512-min

COVID-19 Insights: How a global health crisis changed our everyday behaviour

This eBook is a collection of insights that examine how people’s attitudes and behaviours had...

RECENT POSTS
  • Wellnex Life reports record $3m in monthly sales as it pursues dual listing on LSE
  • Wellnex Life (ASX:WNX) Investor Briefing – 19th December 2024
  • Wellnex ready for dual UK listing in new year after record November sales
  • ASX wellness stocks offering calm and anxiety relief – Part 2
  • Wellnex Life (ASX:WNX) Q&A – 9th February 2024
SHARE THIS POST
  • FB
  • Insta
  • Group 23
Home
About us
Contact us
Privacy Policy




*proposed new name change for Wattle Health Australia Limited (subject to shareholder approval)

This investor centre was built by Reach Markets

©2022 Reach Markets

×

Do you qualify as a Wholesale (708) investor?

Wholesale 708 Sophisticated Investors are individuals or entities who generally qualify under Sections 708(8) and s761G(7) of the Corporations Act based on the gross income and/or net assets test verified by a qualified accountant.
  • A gross income of $250,000 or more per annum in each of the previous two financial years; or
  • Net assets of at least $2.5 million; and
  • A verified Qualified Accountant’s certificate given no more than two (2) years ago confirming the Sophisticated Investor status. Please refer to the Corporations Act: Specifically Section 708(08) and Section s761G(7)